TTD | Drug: D0Q2YH

Drug General Information
Drug ID	D0Q2YH
Former ID	DNC008524
Drug Name	QCPac
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[528982]
Structure		Download 2D MOL 3D MOL
Formula	C13H21N3O5S
Canonical SMILES	CC(C(=O)NC(CS)C(=O)O)NC(=O)C1CCCN1C(=O)C
InChI	1S/C13H21N3O5S/c1-7(11(18)15-9(6-22)13(20)21)14-12(19)10-4-3-5-16(10)8(2)17/h7,9-10,22H,3-6H2,1-2H3,(H,14,19)(H,15,18)(H,20,21)/t7-,9-,10-/m0/s1
InChIKey	YFMHBFVZXDWWRU-HGNGGELXSA-N
PubChem Compound ID	44560285
Target and Pathway
Target(s)	Sodium/glucose cotransporter 1	Target Info	Inhibitor	[528982]
KEGG Pathway	Carbohydrate digestion and absorption
	Bile secretion
	Mineral absorption
PathWhiz Pathway	Lactose Degradation
PathWhiz Pathway	Trehalose Degradation
Reactome	Hexose transport
	Na+-dependent glucose transporters
	Inositol transporters
WikiPathways	NRF2 pathway
	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
	Metabolism of carbohydrates
References
Ref 528982	J Biol Chem. 2007 Sep 28;282(39):28501-13. Epub 2007 Aug 8.Tripeptides of RS1 (RSC1A1) inhibit a monosaccharide-dependent exocytotic pathway of Na+-D-glucose cotransporter SGLT1 with high affinity.
Ref 528982	J Biol Chem. 2007 Sep 28;282(39):28501-13. Epub 2007 Aug 8.Tripeptides of RS1 (RSC1A1) inhibit a monosaccharide-dependent exocytotic pathway of Na+-D-glucose cotransporter SGLT1 with high affinity.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information